Renew Biopharma and Algae-C Announce License Agreement for Best-in-Class Engineered Enzymes
SAN DIEGO--(BUSINESS WIRE)--Renew Biopharma (“Renew”) announced today that Algae-C Inc. (“Algae-C”) has licensed rights to employ Renew’s proprietary engineered enzymes for use toward biosynthesis of cannabinoids in microalgae.